Concepedia

Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

John C. Davis, Désirée van der Heijde, Jürgen Braun, Maxime Dougados, Daniel O. Clegg, Alan Kivitz, Roy Fleischmann, Robert D. Inman, L. Ni, W. Tsuji

Annals of the Rheumatic Diseases · 2007 · 156 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Désirée van der Heijde, Alan Kivitz, Michael Schiff et al. · Arthritis & Rheumatism · 2006 · 878 citations

, , +13

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

John C. Davis, Désirée van der Heijde, Jürgen Braun et al. · Arthritis & Rheumatism · 2003 · 763 citations

, , +8

Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

Jennifer D. Gorman, Kenneth E. Sack, John C. Davis · New England Journal of Medicine · 2002 · 707 citations · Full text

, , +13

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

Jürgen Braun, M. Bollow, Lucia Neure et al. · Arthritis & Rheumatism · 1995 · 689 citations

, , +15

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

Jennifer J. Anderson, Gabriel Baron, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2001 · 610 citations · Full text

, , +13